- Home
- BBVA vs BMY Comparison
BBVA vs BMY Comparison
Compare BBVA & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBVA | BMY |
|---|---|---|
| Founded | 1857 | 1887 |
| Country | Spain | United States |
| Employees | N/A | 32500 |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.5B | 123.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BBVA | BMY |
|---|---|---|
| Price | $21.92 | $59.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 16 |
| Target Price | N/A | ★ $61.81 |
| AVG Volume (30 Days) | 1.8M | ★ 9.9M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | 3.06% | ★ 4.23% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $29.54 | N/A |
| Revenue Next Year | $5.43 | N/A |
| P/E Ratio | ★ $11.24 | $17.26 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.59 | $42.52 |
| 52 Week High | $26.20 | $62.89 |
Technical Indicators
Market Signals| Indicator | BBVA | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 52.47 | 50.79 |
| Support Level | $20.38 | $59.23 |
| Resistance Level | $22.11 | $62.47 |
| Average True Range (ATR) | 0.57 | 1.25 |
| MACD | 0.20 | 0.16 |
| Stochastic Oscillator | 95.16 | 54.55 |
Price Performance
Historical ComparisonAbout BBVA Banco Bilbao Vizcaya Argentaria S.A.
Despite its Spanish origins, Banco Bilbao Vizcaya Argentaria generates only around one-fourth of its profits in Spain. We expect that on a normalized basis, BBVA's market-leading Mexican bank should contribute half of its earnings, while its Turkish operation should account for another 15%. The balance of BBVA's earnings comes from smaller operations in South America. BBVA is overwhelmingly a retail and commercial bank, with corporate and investment banking forming a minor part of the overall business. BBVA also offers insurance and investment products through its banking networks.
About BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.